BRAF and melanoma: As late-stage patients often have multiple tumors in difficult access sites, this technique could allow patients with the unresected disease to be treated with a precision medicine approach as radiomics parameters are derived from routine images, including BRAF inhibitor and/or other immunotherapy treatments for melanoma.